BeOne Medicines (ONC) Free Cash Flow Growth (3y) (2018 - 2026)
BeOne Medicines (ONC) Free Cash Flow Growth (3y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,200.25 Bn | 66,199.96 Bn | - | -5.05% |
| 2 | Nanobiotix | 1,908.00 Bn | 1,907.94 Bn | - | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - | - |
| 4 | BeOne Medicines | 471.75 Bn | 466.96 Bn | 1.35 Bn | 31.07% |
| 5 | Vertex Pharmaceuticals | 121.94 Bn | 114.69 Bn | 2.59 Bn | 14.71% |
| 6 | Regeneron Pharmaceuticals | 69.87 Bn | 61.12 Bn | 3.31 Bn | -10.65% |
| 7 | Belite Bio | 62.43 Bn | 62.43 Bn | - | - |
| 8 | Argenx Se | 55.86 Bn | 50.68 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.49 Bn | 34.48 Bn | 959.66 Mn | 31.42% |
| 10 | Revolution Medicines | 37.05 Bn | 37.05 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 31.07% |
| Dec 31, 2025 | 46.69% |
| Sep 30, 2025 | 35.74% |
| Jun 30, 2025 | 36.93% |
| Mar 31, 2025 | 61.62% |
| Dec 31, 2024 | -11.54% |
| Sep 30, 2024 | 35.73% |
| Jun 30, 2024 | 51.22% |
| Mar 31, 2024 | -90.73% |
| Dec 31, 2023 | 17.53% |
| Sep 30, 2023 | 29.34% |
| Jun 30, 2023 | -17.95% |
| Mar 31, 2023 | -19.45% |
| Dec 31, 2022 | -10.30% |
| Sep 30, 2022 | -35.55% |
| Jun 30, 2022 | -124.96% |
| Mar 31, 2022 | -13.28% |
| Dec 31, 2021 | 36.32% |
| Sep 30, 2021 | -42.18% |
| Jun 30, 2021 | -51.46% |